Fumihiko Mouri Selected Research

Fumihiko Mouri Research Topics

4	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 01/2013
2	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 10/2019 - 11/2012
2	Fever (Fevers) 03/2013 - 11/2005
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 01/2022
1	Febrile Neutropenia 01/2021
1	Neutropenia 01/2021
1	Muscular Atrophy (Muscle Atrophy) 01/2021
1	Lymphoma (Lymphomas) 01/2021
1	Inherited Blood Coagulation Disorders 09/2020
1	Stevens-Johnson Syndrome (Lyell's Syndrome) 10/2019
1	Monoclonal Gammopathy of Undetermined Significance 04/2016
1	Multiple Myeloma 04/2016
1	Chromosome Aberrations (Chromosome Abnormalities) 01/2014
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2014
1	Breakthrough Infections 03/2013
1	Communicable Diseases (Infectious Diseases) 03/2013
1	Mycoses (Diseases, Fungus) 03/2013
1	Zygomycosis (Phycomycosis) 03/2013
1	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 01/2013
1	Cholecystitis 03/2009
1	Inflammation (Inflammations) 01/2008
1	T-Cell Leukemia (Leukemia, T Cell) 12/2007
1	Chills 11/2005
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 11/2005
1	Erythema 11/2005

2	Lenalidomide (CC 5013)FDA Link 10/2019 - 04/2016
1	defibrotideIBA 01/2022
1	Inotuzumab OzogamicinIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 02/2021
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2021
1	Serum AlbuminIBA 01/2021
1	Factor V (Coagulation Factor V)IBA 09/2020
1	Methylprednisolone FDA LinkGeneric 10/2019
1	mogamulizumabIBA 10/2019
1	Intravenous Immunoglobulins (IVIG)FDA Link 10/2019
1	Immunosuppressive Agents (Immunosuppressants)IBA 10/2019
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 10/2019
1	Voriconazole (Vfend)FDA LinkGeneric 03/2013
1	Pharmaceutical PreparationsIBA 03/2013
1	Polymethyl Methacrylate (Sol)IBA 03/2013
1	Histones (Histone)IBA 01/2008
1	HMGB1 Protein (HMG1)IBA 01/2008
1	Proteins (Proteins, Gene)FDA Link 01/2008
1	DNA-Binding Proteins (DNA Binding Protein)IBA 01/2008
1	NF-kappa B (NF-kB)IBA 12/2007
1	Imatinib Mesylate (Gleevec)FDA Link 11/2005

6	Therapeutics 01/2022 - 11/2005
4	Transplantation 01/2022 - 11/2012
3	Stem Cell Transplantation 01/2021 - 03/2013
2	Drug Therapy (Chemotherapy) 01/2021 - 01/2013
1	Hematopoietic Stem Cell Transplantation 01/2022
1	Length of Stay 01/2021
1	Cell Transplantation 10/2019
1	Radiotherapy 04/2016
1	Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation) 01/2013
1	Cardiopulmonary Resuscitation (CPR) 03/2009